Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics

Applied Microbiology and Biotechnology

Volumn 58, Issue 6, 2002, Pages 695-703

  Heath, R ^a,b   White, S ^a,b   Rock, C ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ANTIINFECTIVE AGENT; CARBOXYLASE; CERULENIN; DIAZABORINE; ENZYME; HYDROLYASE; ISOMERASE; ISONIAZID; THIOLACTOMYCIN; TRICLOSAN; UNCLASSIFIED DRUG;

ANTIBIOTICS; BIOTECHNOLOGY;

BACILLUS SUBTILIS; DISSOCIATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SENSITIVITY; ESCHERICHIA COLI; FATTY ACID SYNTHESIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; ENZYMES; FATTY ACIDS;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; PLASMODIUM FALCIPARUM; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036247948     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-001-0918-z     Document Type: Short Survey

References (72)

1. A mechanism of drug action revealed by structural studies of enoyl reductase
2. Mechanism of action of diazaborines
3. + at 2.1 Å resolution
4. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis
5. Triclosan: Applications and safety
6. Inhibition of biotin carboxylase by a reaction intermediate analog: Implications for the kinetic mechanism
7. b-Ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis
8. Biosynthesis of membrane lipids
9. The effectiveness of triclosan-incorporated plastic against bacteria on beef surfaces
10. Inhibition of fatty acid biosynthesis by the antibiotic cerulenin. Specific inactivation of b-ketoacyl-acyl carrier protein synthetase
11. The 1.8 Å cystal structure and active site architecture of β-ketoacyl-[acyl carrier protein] synthase III (FabH) from Escherichia coli
12. Inhibition of Escherichia coli acetyl coenzyme A carboxylase by acyl-acyl carrier protein
13. Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitro
14. Overproduction of acetyl-CoA carboxylase activity increases the rate of fatty acid biosynthesis in Escherichia coli
15. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis
16. Conditional mutants affecting the cell envelope of Escherichia coli
17. Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB
18. Preparation and antibacterial activities of new 1,2,3-diazaborine derivatives and analogues
19. Growth of a bacterial consortium on triclosan
20. Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli
21. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli
22. Roles of the FabA and FabZ β-hydroxy-acyl-acyl carrier protein dehydratases in Escherichia coli fatty acid biosynthesis
23. A triclosan-resistant bacterial enzyme
24. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis
25. Mechanism of triclosan inhibition of bacterial fatty acid synthesis
26. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene
27. The enoyl-[acyl carrier protein] reductases, FabI and FabL, from Bacillus subtilis
28. β-hydroxydecanoyl thioester dehydrase. Specificity of substrates and acetylenic inhibitors
29. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): A target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis
30. Crystal structure of β-ketoacyl-acyl carrier protein synthase II from E.coli reveals the molecular architecture of condensing enzymes
31. Acetoacetyl-acyl carrier protein synthase, a potential regulator of fatty acid biosynthesis in bacteria
32. Aceto-acetyl-acyl carrier protein synthase: A target for the antibiotic thiolactomycin
33. A missense mutation in the fabB (β-ketoacyl-[acyl carrier protein] synthase I) gene confers thiolactomycin resistance to Escherichia coli
34. Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum)
35. Antimicrobial actions of hexachlorophene: Release of cytoplasmic materials
36. Antibacterial efficacy of triclosan-incorporated polymers
37. The antibacterial activity of 3-decynoyl-N-acetyl-cysteamine. Inhibition in vivo of β-hydroxydecanoyl thioester dehydrase
38. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
39. Synthesis and antitumor activity of an inhibitor of fatty acid synthase
40. Effect of a diazaborine derivative (Sa 84.474) on the virulence of Escherichia coli
41. Structure of a dehydratase-isomerase from the bacterial pathway for biosynthesis of unsaturated fatty acids: Two catalytic activities in one active site
42. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors
43. Triclosan targets lipid synthesis
44. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
45. Inhibition of Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid
46. Thiolactomycin a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice
47. Structure of the complex between the antibiotic cerulenin and its target, b-ketoacyl-acyl carrier protein synthase
48. The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast
49. Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity
50. Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties
51. Studies on cerulenin. V. Structure of cerulenin
52. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis by triclosan and isoniazid
53. In vitro activity of a novel antimycobacterial compound. N- octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis
54. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism
55. The structure of β-keto-[acyl carrier protein] reductase from Escherichia coli: Negative cooperativity and its structural basis
56. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis
57. Investigations on the mode of action of triclosan, a broad-spectrum antimicrobial agent
58. Modification of NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis
59. + and a C16 fatty acyl substrate
60. Response of Bacillus subtilis to cerulenin and acquisition of resistance
61. Triclosan: A widely used biocide and its link to antibiotics
62. Antimicrobial actions of hexachlorophene: Cytological manifestations
63. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus
64. Movement of the biotin carboxylase B-domain as a result of ATP binding
65. Isolation and characterization of the β-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12
66. Overproduction of β-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12
67. envM genes of Salmonella typhimurium and Escherichia coli
68. Inactivation of the InhA-encoded fatty acid synthase II (FASII) enoylacyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis
69. Membranotropic effects of the antibacterial agent triclosan
70. Nuclear-endcoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
71. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan
72. Polar allele duplication for transcriptional analysis of consecutive essential genes: Application to a cluster of Escherichia coli fatty acid biosynthetic genes